These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 3055254)

  • 1. Prostate carcinoma investigated by whole organ sections using the Gleason histologic grading system.
    Hostetter A; Pedersen K; Boeryd B; Gustafsson B; Månson J; Engberg A
    Scand J Urol Nephrol Suppl; 1988; 110():163-7. PubMed ID: 3055254
    [No Abstract]   [Full Text] [Related]  

  • 2. Heterogeneity of Gleason grade in multifocal adenocarcinoma of the prostate.
    Arora R; Koch MO; Eble JN; Ulbright TM; Li L; Cheng L
    Cancer; 2004 Jun; 100(11):2362-6. PubMed ID: 15160339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship of cathepsin B and stefin A mRNA localization identifies a potentially aggressive variant of human prostate cancer within a Gleason histologic score.
    Sinha AA; Quast BJ; Korkowski JC; Wilson MJ; Reddy PK; Ewing SL; Sloane BF; Gleason DF
    Anticancer Res; 1999; 19(4B):2821-9. PubMed ID: 10652560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Histologic grading of primary prostatic carcinoma--study of Gleason histologic grading].
    Uchijima Y; Kusuyama H; Okada K
    Hinyokika Kiyo; 1987 Aug; 33(8):1193-8. PubMed ID: 3425519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Histological study of cancer of the prostate].
    Romero Aguirre F; Sanz Esponera J; Lázaro Pérez J; Romero Fernández FJ
    Arch Esp Urol; 1981; 34(5):339-46. PubMed ID: 7036919
    [No Abstract]   [Full Text] [Related]  

  • 6. New developments in grading prostate cancer.
    Miller GJ
    Semin Urol; 1990 Feb; 8(1):9-18. PubMed ID: 2189192
    [No Abstract]   [Full Text] [Related]  

  • 7. Telomerase reverse transcriptase subunit immunoreactivity: a marker for high-grade prostate carcinoma.
    Iczkowski KA; Pantazis CG; McGregor DH; Wu Y; Tawfik OW
    Cancer; 2002 Dec; 95(12):2487-93. PubMed ID: 12467061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update on the Gleason grading system for prostate cancer: results of an international consensus conference of urologic pathologists.
    Epstein JI; Allsbrook WC; Amin MB; Egevad LL
    Adv Anat Pathol; 2006 Jan; 13(1):57-9. PubMed ID: 16462155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of the 2005 international society of urological pathology consensus conference on standard Gleason grading of prostatic carcinoma in needle biopsies.
    Billis A; Guimaraes MS; Freitas LL; Meirelles L; Magna LA; Ferreira U
    J Urol; 2008 Aug; 180(2):548-52; discussion 552-3. PubMed ID: 18550106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative prediction of small volume cancer (less than 0.5 ml) in radical prostatectomy specimens.
    Cheng L; Poulos CK; Pan CX; Jones TD; Daggy JK; Eble JN; Koch MO
    J Urol; 2005 Sep; 174(3):898-902. PubMed ID: 16093983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glandular profiles and cellular patterns in prostatic cancer grading. National Prostatic Cancer Project System.
    Gaeta JF
    Urology; 1981 Mar; 17(Suppl 3):33-7. PubMed ID: 7210369
    [No Abstract]   [Full Text] [Related]  

  • 12. Prostatic carcinoma: histopathologic classification, grading, receptors and markers.
    Capelli A; Carbone A
    Rays; 1993; 18(1):23-32. PubMed ID: 8356238
    [No Abstract]   [Full Text] [Related]  

  • 13. Predictors of Gleason pattern 4/5 prostate cancer on prostatectomy specimens: can high grade tumor be predicted preoperatively?
    Rubin MA; Mucci NR; Manley S; Sanda M; Cushenberry E; Strawderman M; Montie JE; Bassily NH
    J Urol; 2001 Jan; 165(1):114-8. PubMed ID: 11125378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Histological profile, histogenesis and biological assessment of clear-cell microcarcinoma of the prostate].
    Linoli O
    Pathologica; 1984; 76(1041):21-33. PubMed ID: 6379585
    [No Abstract]   [Full Text] [Related]  

  • 15. [Malignancy grade and clinical stage T0-T3 in prostate cancer].
    Wernert N; Goebbels R; Dhom G
    Urologe A; 1986 Jan; 25(1):55-8. PubMed ID: 3962046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thin-needle aspiration biopsy of the prostate.
    Koss LG; Woyke S; Schreiber K; Kohlberg W; Freed SZ
    Urol Clin North Am; 1984 May; 11(2):237-51. PubMed ID: 6203204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathological parameters of radical prostatectomy for clinical stages T1c versus T2 prostate adenocarcinoma: decreased pathological stage and increased detection of transition zone tumors.
    Jack GS; Cookson MS; Coffey CS; Vader V; Roberts RL; Chang SS; Smith JA; Shappell SB
    J Urol; 2002 Aug; 168(2):519-24. PubMed ID: 12131301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Gleason histologic grading of prostate carcinoma in relation to serum PSA, PSA in situ and immunohistochemical expression of 34 beta E12 and P504S].
    Xiao Q; Yin H; Lu Z; Meng K; Zhou X
    Zhonghua Nan Ke Xue; 2004 May; 10(5):362-5. PubMed ID: 15190830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frozen section diagnosis and mucin production in prostatic carcinoma.
    Schaefer JA; Lilien OM; Sandler M
    Invest Urol; 1969 Mar; 6(5):493-504. PubMed ID: 4887492
    [No Abstract]   [Full Text] [Related]  

  • 20. Histopathology of localized prostate cancer. Consensus Conference on Diagnosis and Prognostic Parameters in Localized Prostate Cancer. Stockholm, Sweden, May 12-13, 1993.
    Murphy GP; Busch C; Abrahamsson PA; Epstein JI; McNeal JE; Miller GJ; Mostofi FK; Nagle RB; Nordling S; Parkinson C
    Scand J Urol Nephrol Suppl; 1994; 162():7-42; discussion 115-27. PubMed ID: 7817162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.